Topic: Sanofi-Aventis SA

Sanofi-Aventis ends research on troubled diet drug, 2 weeks after halting sales in EuropeFrench drugmaker Sanofi-Aventis is halting all research on a once-promising diet drug that never made it to the U.S. market. The Paris-based company, in the world's No. 4 drugmaker, ...

Sanofi-Aventis suspends sales of anti-obesity drug Acomplia in EuropeFrench pharmaceutical company Sanofi-Aventis temporarily suspended sales of anti-obesity drug Acomplia in Europe, the company said Thursday, after health authorities said the drug's risks outweigh its benefits. Sanofi-Aventis will "immediately" start talks with non-EU ...